Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC
0:20
Gilead CEO Daniel O’Day breaks down the company's new twice-a-…
1.2K viewsJan 12, 2023
FacebookCNBC
The FDA has approved a highly effective new HIV-prevention medication, Gilead Sciences reported. | NBC News
0:26
The FDA has approved a highly effective new HIV-prevention medi…
7.2K views10 months ago
FacebookNBC News
COVID-19 patients respond to Gilead drug: report
1:06
COVID-19 patients respond to Gilead drug: report
Apr 17, 2020
YahooReuters Videos
In a critical announcement that brings hope to millions around the world, Gilead Sciences, which is in the midst of critical Phase 3 trials of the drug Remdesivir in coronavirus patients, said that a breakthrough has been achieved. | NDTV
23:12
In a critical announcement that brings hope to millions around th…
146.6K viewsApr 29, 2020
FacebookNDTV
Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions
Gilead to pay $202 million to settle doctor kickback claims related to …
11 months ago
NBC10 PhiladelphiaDan Mangan,CNBC
Gilead: Phase 3 study data shows remdesivir helped patients with moderate Covid-19
1:16
Gilead: Phase 3 study data shows remdesivir helped patients with m…
Jun 1, 2020
CNBCMeg Tirrell
Coronavirus patients reportedly responding to Gilead's experimental treatment
2:30
Coronavirus patients reportedly responding to Gilead's experiment…
Apr 17, 2020
CNBC
0:43
For more than 35 years, Gilead has been at the forefront of tackling so…
74.5K views11 months ago
FacebookGilead Sciences
2:50
Gilead Sciences CEO on raising full-year guidance due to remdesivir s…
Jan 11, 2021
CNBCMeg Tirrell
3:11
Gilead Sciences posts mixed Q1 results
11 months ago
Yahoo
2:38
Gilead Sciences earnings top estimates, boosts full-year outlook
10.1K views8 months ago
YahooYahoo Finance Video
FDA approves Gilead's remdesivir, first drug for treating COVID-19
Oct 22, 2020
fox13news.com
2:51
AstraZeneca Is Said to Approach Gilead About Potential Merger
Jun 7, 2020
Bloomberg.comEd Hammond,Aaron Kirchfeld,Dinesh Nair
Gilead HIV combo of bictegravir & lenacapavir hits phase 3 goal
4 months ago
marketscreener.com
0:28
These are Gilead scientists. They’re not just experts in oncology, virol…
93.8K views8 months ago
FacebookGilead Sciences
7:07
Gilead Signs Deal to Expand HIV Drug Access in 120 Developing He…
Nov 14, 2024
humix.com
7:12
Reporter behind Gilead Covid-19 drug story on findings
Apr 17, 2020
CNBC
#gileadnews #hiv | Gilead Sciences | 29 comments
29 viewsFeb 18, 2025
linkedin.com
1:05
At Gilead, patients are at the heart of everything we do – and we’re focu…
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:46
We’re paving the way for the future pipeline in oncology and inflamma…
178 views7 months ago
FacebookGilead Sciences
5:24
Gilead CEO Daniel O'Day on new HIV prevention medicine: It's goin…
Jan 13, 2025
CNBCAngelica Peebles
7:15
Gilead Sciences CEO Daniel O'Day: We have the most robust pipeline …
3 months ago
CNBC
0:08
We’re digging in and building a future pipeline of medicine right h…
631 views6 months ago
FacebookGilead Sciences
A Supreme Court Vote Buoyed Gilead, Exact. Here's Why.
9 months ago
investors.com
Gilead Stock Dives On A Devastating Potential Call From HHS
Mar 19, 2025
investors.com
Gilead Sciences: Global Health and Access
Sep 17, 2024
gilead.com
3:46
Gilead CEO Daniel O'Day: Ending the HIV epidemic is our goal
Jan 9, 2023
CNBC
1:00
Truvada, Viread, Atripla, Stribild, Complera Potential Side Effects M…
370.1K viewsOct 8, 2021
FacebookDrug Injury News
Gilead Sciences: A Mixed Bag of Opportunities and Risks | The Mot…
9 months ago
fool.com
Gilead Sciences, Inc. Stock (GILD) - Quote Nasdaq- MarketScreener
Aug 18, 2020
marketscreener.com
See more videos
Static thumbnail place holder